Cargando…
Sample Size Requirements for Studies of Treatment Effects on Beta-Cell Function in Newly Diagnosed Type 1 Diabetes
Preservation of [Image: see text]-cell function as measured by stimulated C-peptide has recently been accepted as a therapeutic target for subjects with newly diagnosed type 1 diabetes. In recently completed studies conducted by the Type 1 Diabetes Trial Network (TrialNet), repeated 2-hour Mixed Mea...
Autores principales: | Lachin, John M., McGee, Paula L., Greenbaum, Carla J., Palmer, Jerry, Pescovitz, Mark D., Gottlieb, Peter, Skyler, Jay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213096/ https://www.ncbi.nlm.nih.gov/pubmed/22102862 http://dx.doi.org/10.1371/journal.pone.0026471 |
Ejemplares similares
-
Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data
por: Greenbaum, Carla J., et al.
Publicado: (2012) -
Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial
por: Lachin, John M., et al.
Publicado: (2014) -
Failure to Preserve β-Cell Function With Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients With New- Onset Type 1 Diabetes
por: Gottlieb, Peter A., et al.
Publicado: (2010) -
Newly Diagnosed Idiopathic Liver Abscess: Colonoscopy Required!
por: Makkar, Priyanka, et al.
Publicado: (2017) -
Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes
por: Greenbaum, Carla J., et al.
Publicado: (2008)